You are here
The identity of C+D's long-running contributor remains a mystery, but his irreverent views are known by all. Tweet him @Xrayser
Xrayser (0 articles)
Over the weekend I read the C+D article about the petition protesting the “unsuitable” June pre-registration exam, which apparently has received more...
It’s becoming a strange summer, with unremittingly sunny weather and uncharacteristic English sporting success. But of course some things never...
I was giving a talk to a local stroke group this week when someone asked the question about aspirin. You know, the “should I take a low-dose aspirin...
“PSNC still not agreed new price concession system,” ran the C+D headline last week. Although, to be honest, it could have been any week. “Same story...
Since the dawn of humanity we’ve divided the world into those who are prepared and those who simply drift through life like a Brexit negotiation. In...
When I first registered as a pharmacist, my favourite book was called Minor illness or major disease. This over-the-counter prescribing guide gave...
There’s much talk over the past year about robots taking over everyone’s role, with auditors PricewaterhouseCoopers suggesting more than 10 million...
It’s that time of year when selling reaches a new peak, as customers fight over £200 beauty advent calendars and retailers grasp just how much tat...
The lady at the counter looked to be in her 50s. She wore black leather gloves on her hands and a tired and hassled expression on her face. “My son...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter